At this year’s CES AgeTech Collaborative™, hosted by AARP, leadership from The 10,000 Brains Project joined a panel of experts to explore the rapidly evolving landscape of cognitive care. The discussion brought together voices from across science and innovation, including Dr. Christin Glorioso of NeuroAge Therapeutics and James Mayer of the Centre for Aging + Brain Health Innovation.

A central theme of the conversation was the tangible progress being made toward improving outcomes for individuals at risk of cognitive decline. Dr. Glorioso highlighted how her team is leveraging multimodal patient data to predict risk for Alzheimer’s disease and develop personalized prevention strategies—signaling a shift from reactive to proactive care.

In parallel, The 10,000 Brains Project is advancing this vision by building large-scale digital neuropathology datasets. These efforts aim to deepen understanding of the biological complexity underlying neurodegenerative diseases and lay the groundwork for more precise, individualized approaches to care. As additional data modalities are integrated over time, the potential for more powerful and predictive cognitive care tools will continue to expand.

The panel also underscored the importance of ethics and trust in driving adoption. While consumers increasingly recognize the promise of data-driven cognitive health technologies, concerns around data privacy, security, and scientific credibility remain paramount. Panelists emphasized that ensuring transparency and grounding innovations in rigorous science will be essential to maintaining public trust and accelerating progress.

As technology continues to shape the future of brain health, collaboration emerged as a critical enabler. The 10,000 Brains Project remains committed to supporting the global research ecosystem through data generation, training, and funding—while actively bridging the gap between neuroscience and technology innovators.

The discussion reflected a shared sense of optimism: a future defined by earlier detection, actionable prevention, and truly personalized cognitive care—made possible through cross-sector collaboration and responsible innovation.